B Group, Inc. has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $117 Billion distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $46B, Insmed Inc with a value of $20B, Zai Lab LTD with a value of $14.5B, Akero Therapeutics, Inc. with a value of $9.82B, and Iovance Biotherapeutics, Inc. with a value of $5B.

Examining the 13F form we can see an decrease of $46.9B in the current position value, from $164B to 117B.

B Group, Inc. is based out at Dallas, TX

Below you can find more details about B Group, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $117 Billion
Healthcare: $110 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 19
  • Current Value $117 Billion
  • Prior Value $164 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track B Group, Inc. Portfolio

Follow B Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on B Group, Inc. with notifications on news.